
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $2.2M | $3.3M | $3.2M | $2.8M | |
Selling, General & Admin | -- | $1.5M | $1.2M | $1.1M | $4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -$17.3K | |
Operating Expenses | -- | $4.8M | $4.4M | $4.3M | $6.8M | |
Operating Income | -- | -$4.8M | -$4.4M | -$4.3M | -$6.8M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -$7.4M | -$6.3M | -$7.8M | -$8.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$7.4M | -$6.3M | -$7.8M | -$8.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$7.4M | -$6.3M | -$7.8M | -$8.9M | |
Basic EPS (Cont. Ops) | -- | -$0.33 | -$0.32 | -$0.38 | -$0.88 | |
Diluted EPS (Cont. Ops) | -- | -$0.33 | -$0.32 | -$0.38 | -$0.88 | |
Weighted Average Basic Share | -- | $23.1M | $23.1M | $20.6M | $12.4M | |
Weighted Average Diluted Share | -- | $23.1M | $23.1M | $20.6M | $12.4M | |
EBITDA | -- | -$4.8M | -$4.4M | -$4.3M | -$6.8M | |
EBIT | -- | -$4.8M | -$4.4M | -$4.3M | -$6.8M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -$4.8M | -$4.4M | -$4.3M | -$6.8M | |
Operating Income (Adjusted) | -- | -$4.8M | -$4.4M | -$4.3M | -$6.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $684.8K | $753.8K | $361.8K | $1.3M | |
Selling, General & Admin | -- | $203.4K | $294.3K | $268.4K | $3.7M | |
Other Inc / (Exp) | -- | -- | -- | -- | $1.1M | |
Operating Expenses | -- | $889.4K | $1M | $630.2K | $5M | |
Operating Income | -- | -$889.4K | -$1M | -$630.2K | -$5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -$1.4M | -$1.8M | -$1.5M | -$3.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$1.4M | -$1.8M | -$1.5M | -$3.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$1.4M | -$1.8M | -$1.5M | -$3.9M | |
Basic EPS (Cont. Ops) | -- | -$0.06 | -$0.09 | -$0.07 | -$0.18 | |
Diluted EPS (Cont. Ops) | -- | -$0.06 | -$0.09 | -$0.07 | -$0.18 | |
Weighted Average Basic Share | -- | $23.3M | $23.1M | $20.6M | $21.2M | |
Weighted Average Diluted Share | -- | $23.3M | $23.1M | $20.6M | $21.2M | |
EBITDA | -- | -$889.4K | -$1M | -$629.5K | -$3.9M | |
EBIT | -- | -$889.4K | -$1M | -$630.2K | -$3.9M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -$889.4K | -$1M | -$630.2K | -$5M | |
Operating Income (Adjusted) | -- | -$889.4K | -$1M | -$630.2K | -$3.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | $2.8M | $3.8M | |
Selling, General & Admin | -- | -- | -- | $1.1M | $7.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | $1.1M | |
Operating Expenses | -- | -- | -- | $3.9M | $11.2M | |
Operating Income | -- | -- | -- | -$3.9M | -$11.2M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$7.4M | -$11.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -$7.4M | -$11.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$7.4M | -$11.3M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.37 | -$0.67 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.37 | -$0.67 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -$3.9M | -$10.1M | |
EBIT | -- | -- | -- | -$3.9M | -$10.1M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -$3.9M | -$11.2M | |
Operating Income (Adjusted) | -- | -- | -- | -$3.9M | -$10.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $684.8K | $753.8K | $361.8K | $1.3M | |
Selling, General & Admin | -- | $203.4K | $294.3K | $268.4K | $3.7M | |
Other Inc / (Exp) | -- | -- | -- | -- | $1.1M | |
Operating Expenses | -- | $889.4K | $1M | $630.2K | $5M | |
Operating Income | -- | -$889.4K | -$1M | -$630.2K | -$5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -$1.4M | -$1.8M | -$1.5M | -$3.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$1.4M | -$1.8M | -$1.5M | -$3.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$1.4M | -$1.8M | -$1.5M | -$3.9M | |
Basic EPS (Cont. Ops) | -- | -$0.06 | -$0.09 | -$0.07 | -$0.18 | |
Diluted EPS (Cont. Ops) | -- | -$0.06 | -$0.09 | -$0.07 | -$0.18 | |
Weighted Average Basic Share | -- | $23.3M | $23.1M | $20.6M | $21.2M | |
Weighted Average Diluted Share | -- | $23.3M | $23.1M | $20.6M | $21.2M | |
EBITDA | -- | -$889.4K | -$1M | -$629.5K | -$3.9M | |
EBIT | -- | -$889.4K | -$1M | -$630.2K | -$3.9M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -$889.4K | -$1M | -$630.2K | -$5M | |
Operating Income (Adjusted) | -- | -$889.4K | -$1M | -$630.2K | -$3.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $80.8K | $171.5K | $39K | $5.5M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | $960 | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | $312.8K | $496.8K | $790K | $5.5M | |
Property Plant And Equipment | -- | $13.1K | $12.3K | $8.1K | $5.3K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | $325.9K | $509.1K | $798.1K | $5.5M | |
Accounts Payable | -- | $856.5K | $1.2M | $2.7M | $1.7M | |
Accrued Expenses | -- | $934K | $1.7M | $2.3M | $618.3K | |
Current Portion Of Long-Term Debt | -- | -- | -- | $14.6M | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | $1.6M | $3M | $4.7M | $2M | |
Total Current Liabilities | -- | $3.5M | $6.1M | $24.7M | $4.6M | |
Long-Term Debt | -- | $7.1M | $10.3M | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $11.8M | $18.1M | $24.8M | $10.8M | |
Common Stock | -- | $11.3K | $6.3K | $6.6K | $20.9K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -$11.5M | -$17.6M | -$24M | -$5.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -$11.5M | -$17.6M | -$24M | -$5.2M | |
Total Liabilities and Equity | -- | $325.9K | $509.1K | $798.1K | $5.5M | |
Cash and Short Terms | -- | $80.8K | $171.5K | $39K | $5.5M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $355.2K | $100.2K | $3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | $1.1M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | $939K | $1M | $4.1M | |
Property Plant And Equipment | -- | -- | $12.2K | $7.4K | $4.6K | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | $150K | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | $951.2K | $1M | $4.2M | |
Accounts Payable | -- | -- | $1.8M | $2.8M | $1.6M | |
Accrued Expenses | -- | -- | $1.9M | $2.5M | $364.7K | |
Current Portion Of Long-Term Debt | -- | -- | -- | $15.5M | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | $3.4M | $5.2M | $1.2M | |
Total Current Liabilities | -- | -- | $7.3M | $26.5M | $3.5M | |
Long-Term Debt | -- | -- | $11.4M | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $19.7M | $26.6M | $8.4M | |
Common Stock | -- | -- | $12K | $6K | $21.4K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | $1.1M | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -$18.7M | -$25.5M | -$4.2M | |
Total Liabilities and Equity | -- | -- | $951.2K | $1M | $4.2M | |
Cash and Short Terms | -- | -- | $355.2K | $100.2K | $3M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$7.4M | -$6.3M | -$7.8M | -$8.9M | |
Depreciation & Amoritzation | -- | $810 | $810 | $4.2K | $2.8K | |
Stock-Based Compensation | -- | -- | -- | -- | $268.3K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$4.4M | -$3.8M | -$3M | -$7.3M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | $200.5K | $230.9K | $1.2K | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $3M | $3.8M | $3.2M | $1.8M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$250K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $100K | -$172K | -$284.2K | -- | |
Cash From Financing | -- | $3.1M | $3.7M | $2.9M | $12.8M | |
Beginning Cash (CF) | -- | $1.2M | $80.8K | $171.5K | $39K | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$1.2M | $90.7K | -$132.5K | $5.5M | |
Ending Cash (CF) | -- | $80.8K | $171.5K | $39K | $5.5M | |
Levered Free Cash Flow | -- | -$4.4M | -$3.8M | -$3M | -$7.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$1.4M | -$1.8M | -$1.5M | -$3.9M | |
Depreciation & Amoritzation | -- | -- | $100 | $700 | $700 | |
Stock-Based Compensation | -- | -- | -- | -- | $941.3K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$960.9K | -$428.2K | -$641.7K | -$3.4M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | $1.2K | -- | -$173.6K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $925K | $775K | $851K | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$164.2K | -$148K | -- | |
Cash From Financing | -- | $925K | $610.8K | $703K | $1.1M | |
Beginning Cash (CF) | -- | $80.8K | $171.5K | $39K | $5.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$35.9K | $183.7K | $61.3K | -$2.6M | |
Ending Cash (CF) | -- | $44.9K | $355.2K | $100.2K | $3M | |
Levered Free Cash Flow | -- | -$960.9K | -$428.2K | -$641.7K | -$3.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$7.4M | -$11.3M | |
Depreciation & Amoritzation | -- | -- | -- | $4.8K | $2.8K | |
Stock-Based Compensation | -- | -- | -- | -- | $1.2M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$3.2M | -$10.1M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -$173.6K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $3.2M | $900K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$268K | -- | |
Cash From Financing | -- | -- | -- | $3M | $13.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -$255K | $2.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -$3.2M | -$10.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$1.4M | -$1.8M | -$1.5M | -$3.9M | |
Depreciation & Amoritzation | -- | -- | $100 | $700 | $700 | |
Stock-Based Compensation | -- | -- | -- | -- | $941.3K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$960.9K | -$428.2K | -$641.7K | -$3.4M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | $1.2K | -- | -$173.6K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $925K | $775K | $851K | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$164.2K | -$148K | -- | |
Cash From Financing | -- | $925K | $610.8K | $703K | $1.1M | |
Beginning Cash (CF) | -- | $80.8K | $171.5K | $39K | $5.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$35.9K | $183.7K | $61.3K | -$2.6M | |
Ending Cash (CF) | -- | $44.9K | $355.2K | $100.2K | $3M | |
Levered Free Cash Flow | -- | -$960.9K | -$428.2K | -$641.7K | -$3.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.